Peter Nash - Griffith University;Rheumatology Research Unit;Rheumatology Department, Sunshine Coast University Hospital;University of Queensland

基本信息

Career Trajectory

Bio

Professor Peter Nash’s research interests include metabolic bone disease and novel therapeutics.

Professor Nash’s group at the Rheumatology Research Unit have been involved with clinical trials concerning all modern targeted biologic therapies and osteoporosis therapies.

Professor Nash has published over 200 peer-reviewed publications - journal articles, conference papers and 5 book chapters. He acts as a peer reviewer for a number of clinical research journals while being on the editorial boards of Annals of the Rheumatic Diseases and RMD Open. Therefore, he is recognised as a research leader in the area of rheumatology.

Research Interests

Papers共 584 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Long-term Tofacitinib Efficacy and Safety in Psoriatic Arthritis with or Without Prior Biologic DMARD Exposure: a Post Hoc Analysis

Dafna D Gladman,Maxime Dougados,Helena Marzo-Ortega, Mary Jane Cadatal,Ekta Agarwal, Cassandra D Kinch,Peter Nash

Rheumatology advances in practiceno. 2 (2025): rkaf008-rkaf008

Cited0Views0WOSBibtex

Safety of Janus Kinase Inhibitors in Immune-Mediated Inflammatory Diseases - a Systematic Literature Review Informing the 2024 Update of an International Expert Consensus Statement

Victoria Konzett,Josef S Smolen,Peter Nash,Kevin Winthrop,Daniel Aletaha,Thomas Dörner,Roy Fleischmann,Yoshiya Tanaka,Jette Primdahl,Xenofon Baraliakos,Iain B McInnes,Michael Trauner,Naveed Sattar,Maarten de Wit,Jan W Schoones,Andreas Kerschbaumer

Annals of the rheumatic diseasesno. 5 (2025): 697-715

Cited0Views0WOSBibtex

Expert Consensus Statement on the Treatment of Immune-Mediated Inflammatory Diseases with Janus Kinase Inhibitors: 2024 Update

Annals of the rheumatic diseasesno. 5 (2025): 664-679

Cited0Views0WOSBibtex

The Use of Disease Activity Thresholds for the Psoriatic Arthritis Impact of Disease Questionnaire to Assess Patient Perceptions of Disease Burden in Patients with Early Oligoarticular Psoriatic Arthritis Treated with Apremilast in a Phase 4 Trial

Laure Gossec,Laura Coates,Dafna Gladman,Alexis Ogdie,Peter Nash,Denis Poddubnyy,Arthur Kavanaugh,April Armstrong,Carlo Selmi,Ruben Queiro Silva,Cynthia Deignan,Rebecca Wang,Jyotsna Reddy,Michele Brunori,Philip Mease

ARTHRITIS & RHEUMATOLOGY (2024): 2976-2978

Cited0Views0Bibtex

Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis by Baseline C-Reactive Protein Level: Post Hoc Analysis of Phase II and Phase III Clinical Trials

Atul Deodhar,Xenofon Baraliakos,Marina Nighat Magrey,Lianne Gensler,Amit V. Thorat, Surya Pemmaraju,Mary Jane Cadatal,Peter Nash

The Journal of Rheumatology（2024）

Cited0Views0WOSBibtex

47 Clinical Characteristics, Outcomes, and Management of In-Stent Restenosis in a Tertiary Referral Centre: a Single Centre Cohort Study

N Leahy, O Galvin,P Nash,J Crowley,F Sharif,D Mylotte,B MacNeill,B Hynes,A McInerney

General posters (2024)

Cited0Views0Bibtex

Efficacy and Safety of Tofacitinib in an Open-Label, Long-Term Extension Study in Patients with Psoriatic Arthritis Who Received Adalimumab or Tofacitinib in a Phase 3 Randomized Controlled Study: A Post Hoc Analysis

Dafna D. Gladman,Peter Nash,Philip J. Mease,Oliver FitzGerald, Stephanie Duench,Mary Jane Cadatal,Karim R. Masri

ARTHRITIS RESEARCH & THERAPYno. 1 (2024)

Cited0Views0WOSBibtex

16 Procedural Aspects and In-Hospital Outcomes of Angiography Versus Intracoronary Imaging Guided Intravascular Lithotripsy for Calcified Coronary Lesions: a Single-Centre Experience

A Mohamed Khair,B Hynes,B MacNeill,F Sharif,D Mylotte,J Crowley,P Nash,A McInerney

Oral abstract presentations 3 (2024)

Cited0Views0Bibtex

Subcutaneous Abatacept Vs Adalimumab Head-to-Head Comparison in Adults with Early, Dual Seropositive Rheumatoid Arthritis, Positive for the Shared Epitope HLA Class II Risk Alleles, and an Inadequate Response to Methotrexate: Results from a Phase 3 Trial

Michael Weinblatt,Paul Emery,Vivian Bykerk,Andrew Cope,Gerd Burmester,Yoshiya Tanaka,Gustavo Citera,Peter Nash, Quentin Dornic,Sheila Kelly,Michael Maldonado

ARTHRITIS & RHEUMATOLOGY (2024): 5417-5419

Cited0Views0Bibtex

SAFETY IN PATIENTS WITH LATENT TUBERCULOSIS WHO RECEIVED CONCOMITANT ANTITUBERCULOSIS MEDICATIONS: ANALYSIS OF 11 STUDIES OF GUSELKUMAB IN PSORIATIC DISEASE

Luis Puig,Tsen-Fang Tsai,Enrique R. Soriano,Tina Bhutani,Megan Miller,Alexa P. Kollmeier, Shu Li,Yin You, Melissa Petrick, Hewei Li, Hetal Patel,Frederic Lavie,Melinda Gooderham,Angela Londono,Mark Lebwohl,Peter Nash

ARTHRITIS & RHEUMATOLOGY (2024): 4148-4150

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn